Genomics insights of candidiasis: mechanisms of pathogenicity and drug resistance

Xin Huang1,2, Qin Dong1, Qi Zhou1

  • 1Key Laboratory of Biodiversity Conservation and Characteristic Resource Utilization in Southwest Anhui, Anqing Forestry Technology Innovation Research Institute, School of Life Sciences, Anqing Normal University, Anqing, China.

PubMed

Insights

Genomics research is advancing our understanding of candidiasis infections and Candida

Area of Science:

  • Medical Mycology
  • Genomics
  • Infectious Diseases

Background:

  • Candidiasis, caused by *Candida* fungi, is a growing concern due to increasing pathogenicity and antifungal drug resistance.
  • Genomic technologies provide crucial tools for studying *Candida*'s virulence and resistance mechanisms.

Purpose of the Study:

  • To review the applications of genomics in candidiasis research.
  • To explore *Candida*'s pathogenic features, virulence factors, and genomic basis of drug resistance.
  • To outline future research directions and inform clinical strategies.

Main Methods:

  • Review of current literature on genomics applications in candidiasis.
  • Analysis of genome sequencing, comparative genomics, and functional genomics studies.
  • Examination of genomic variations linked to drug resistance in *Candida*.

Main Results:

  • Genomics has significantly enhanced the investigation of *Candida* pathogenicity and drug resistance.
  • Genomic variations play a key role in the evolution of antifungal resistance.
  • Understanding these mechanisms provides insights into *Candida*'s adaptability.

Conclusions:

  • Genomics offers a powerful framework for candidiasis research.
  • Further exploration is needed to develop effective clinical treatments and public health interventions.
  • This review provides a foundation for future studies on candidiasis and *Candida* evolution.